1. Hart BJ, Dyall J, Postnikova E, Zhou H, Kindrachuk J, Johnson RF, Olinger GG, Frieman MB, Holbrook MR, Jahrling PB, Hensley L. Interferon-p and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. J Gen Virol. 2014;95(Pt 3):571—577. doi: 10.1099/vir.0.061911-0.
2. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/. Accessed 21 April 2020.
3. TOFAcitinib in SARS-CoV2 Pneumonia. ClinicalTrials.gov Identifier: NCT04332042. Available at https://clinicaltrials.gov/ct2/show/NCT04332042#fireglass_params&tabid=aebc706216c4a74f&start_with_session_counter=3&application_server_address=pfizer3.prod.fire.glass. Accessed 21 April 2020.
4. Vremennye metodicheskie rekomendatsii «Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Versiya 6» (utv. Ministerstvom zdravookhraneniya RF 28 aprelya 2020 g.). [Elektronnyi resurs]. URL: https://base.garant.ru/73964533/
5. Metodicheskie rekomendatsii FAR «Anesteziologo-reanimatsionnoe obespechenie patsientov s novoi koronavirusnoi infektsiei (COVID-19)» (versiya № 2 ot 18 aprelya 2020 goda). [Elektronnyi resurs]. URL: http://www.far.org.ru/newsfar/496-metreccovid19